Safety and clinical usage of newcastle disease virus in cancer therapy
/in International Publications, Newcastle Disease Virus /von 2011-10-26 / J. Biomed. Biotechnol. 2011;2011:718710Importance of retinoic acid-inducible gene I and of receptor for type I interferon for cellular resistance to infection by Newcastle disease virus
/in International Publications, IOZK Veröffentlichungen, Newcastle Disease Virus /von 2011-10-04 / Int. J. Oncol. 2012 Jan;40(1):287-98Apoptin enhances the oncolytic properties of Newcastle disease virus
/in International Publications, Newcastle Disease Virus /von 2011-08-24 / Intervirology 2012;55(4):276-86Improvement of dendritic cell therapy in glioblastoma multiforme WHO 4 by Newcastle disease virus.
/in Dendritic Cells, Glioblastoma, International Publications, Newcastle Disease Virus /von 2011-06-06 / J Clin Oncol 29: 2011 (suppl; abstr 2508)Oncolytic viruses for the treatment of neuroendocrine tumors
/in International Publications, Newcastle Disease Virus /von 2011-05-30 / Horm. Metab. Res. 2011 Nov;43(12):877-83Important role of interferon regulatory factor (IRF)-3 in the interferon response of mouse macrophages upon infection by Newcastle disease virus
/in International Publications, IOZK Veröffentlichungen, Newcastle Disease Virus /von 2011-05-09 / Int. J. Oncol. 2011 Aug;39(2):493-504Oncolytic specificity of Newcastle disease virus is mediated by selectivity for apoptosis-resistant cells
/in International Publications, Newcastle Disease Virus /von 2011-04-06 / J. Virol. 2011 Jun;85(12):6015-23Caspase- and p38-MAPK-dependent induction of apoptosis in A549 lung cancer cells by Newcastle disease virus
/in International Publications, Newcastle Disease Virus, NSCLC /von 2011-04-06 / Arch. Virol. 2011 Aug;156(8):1335-44Targeting of IL-2 and GM-CSF immunocytokines to a tumor vaccine leads to increased anti-tumor activity
/in Dendritic Cells, International Publications, IOZK Veröffentlichungen, Newcastle Disease Virus /von 2011-03-17 / Int. J. Oncol. 2011 Jun;38(6):1719-29IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de